AVIR
Atea Pharmaceuticals Inc
5.30$
+2.1%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Cash Flow
Atea Pharmaceuticals Inc (AVIR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -132 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -7.9 | -13 | 297 | -87 | -121 | -85 | -135 | -132 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.4 | 0.4 | 0.4 | |
| 0.4 | 0.6 | 7.5 | 40 | 47 | 49 | 52 | 21 | |
| 0.4 | 0.6 | 7.5 | 40 | 41 | – | – | – | |
| 0.7 | 0.6 | 300 | -248 | -47 | 16 | -7.5 | 16 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 1.9 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | -455 | 40 | 56 | 189 | |
| – | – | 532 | 1.5 | – | – | 0.0 | -26 | |
| 27 | 0.0 | 532 | 1.5 | 0.4 | 0.3 | 0.3 | -26 | |
| 20 | -13 | 828 | -86 | -576 | -45 | -79 | 31 | |
| -7.9 | -13 | 297 | -87 | -123 | -85 | -135 | -132 |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.